Literature DB >> 9780160

Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides.

T W Redford1, A K Yi, C T Ward, A M Krieg.   

Abstract

Certain sequences of nucleotides (CpG motifs) in bacterial DNA or synthetic oligonucleotides (CpG DNA) promote the production of proinflammatory cytokines, including TNF-alpha, IFN-gamma, IL-6, and IL-12. Here we demonstrate that the immunosuppressant cyclosporin A (CsA) unexpectedly enhanced CpG DNA-induced IL-12 production in murine splenocytes. CsA did not inhibit CpG DNA-induced TNF-alpha or IL-6 production, but decreased the production of IFN-gamma by CpG DNA. Upon examining mechanisms by which CsA increases IL-12 production, we found that CpG DNA can also induce IL-10 production in B cells and that this production was sensitive to CsA. IL-10 has anti-inflammatory effects and can reduce the production of IL-12. To determine the possible role of CsA-modulated IL-10 production in mediating the increased IL-12 levels, splenocytes from IL-10 gene-disrupted mice (IL-10 -/-) and splenocytes cultured in anti-IL-10 Ab were studied. CpG DNA-stimulated IL-10 (-/-) splenocytes demonstrated no increase in IL-12 levels in the presence of CsA. Anti-IL-10 Ab treatment of normal splenocytes increased the magnitude of CpG DNA-induced IL-12 production to that seen with CsA. These results suggest that CpG DNA induces CsA-sensitive IL-10 production in B cells and that IL-10 acts as a negative feedback regulator of CpG DNA-induced IL-12 production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780160

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses.

Authors:  G Haskó; C Szabó
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 2.  Signal transduction induced by immunostimulatory CpG DNA.

Authors:  A M Krieg
Journal:  Springer Semin Immunopathol       Date:  2000

3.  Impact of site-specific nucleobase deletions on the arthritogenicity of DNA.

Authors:  Jan L Bjersing; Andrej Tarkowski; Ekambar R Kandimalla; Helen Karlsson; Sudhir Agrawal; L Vincent Collins
Journal:  Inflammation       Date:  2004-06       Impact factor: 4.092

4.  Interferon-gamma priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages.

Authors:  Miriam V Liscovsky; Romina P Ranocchia; Carolina V Gorlino; Diego O Alignani; Gabriel Morón; Belkys A Maletto; María C Pistoresi-Palencia
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

5.  Unmethylated CpG oligodeoxynucleotides activate head kidney leukocytes of Atlantic cod, Gadus morhua.

Authors:  Christopher Marlowe A Caipang; Sanchala Gallage; Carlo C Lazado; Monica F Brinchmann; Viswanath Kiron
Journal:  Fish Physiol Biochem       Date:  2010-03-28       Impact factor: 2.794

6.  Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells.

Authors:  Angelo Mena; Anil K Nichani; Yurij Popowych; Dale L Godson; Donna Dent; Hugh G G Townsend; George K Mutwiri; Rolf Hecker; Lorne A Babiuk; Philip Griebel
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

7.  A role for TLR signaling during B cell activation in antiretroviral-treated HIV individuals.

Authors:  Basile Siewe; Ali Keshavarzian; Audrey French; Patricia Demarais; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-16       Impact factor: 2.205

8.  Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses.

Authors:  Kunihiko Kitagaki; Vipul V Jain; Thomas R Businga; Iftikhar Hussain; Joel N Kline
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

9.  Mechanism of Mitochondrial Transcription Factor A Attenuation of CpG-Induced Antibody Production.

Authors:  Christopher S Malarkey; Claire E Gustafson; Jessica F Saifee; Raul M Torres; Mair E A Churchill; Edward N Janoff
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.